Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • *#1*
    Junior Member
    • Jul 2010
    • 8

    How to circularize plasmid assembly

    Hi,
    My assembly resulted in a single contig, which is linear. How do I check where is the complimentary sequences on the ends so that I could circularize the plasmid? Is there a tool that can do that easily?

    The thing is I have ran several assemblies and got several one-contigs, but they differ slightly in size, so I expect the difference to be in tails. I have aligned the contigs in Mauve and see that 95% of contigs overlap, but I still cannot figure out where to trim the tails so that I could circularize the plasmid.

    I would appreciate any help and pointers.
    Thanks!
  • maubp
    Peter (Biopython etc)
    • Jul 2009
    • 1544

    #2
    You can use tools like mummerplot to compare the contig to itself, and thus deduce the circle.

    Since (AFAIK) no read mappers support a circular reference, you can check the circle like so: Once you've made the circle, try mapping the reads to it. Then shift the origin (say half way along) and repeat this mapping. Both times you should get nice uniform coverage. Or, take two copies of the circle as a single long reference, and map the reads to that - again you're looking for nice uniform coverage.

    Comment

    • ians
      Member
      • Aug 2011
      • 53

      #3
      What you could do is chop your sequence in half (at what ever break point is appropriate) and then run it through minimus2 or another OLC. If you get one contig back, you now have a perfect linear representation of a circular plasmid. Now you know that the ends can be connected bluntly.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        Today, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:10 AM
      0 responses
      7 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Working...